69 related articles for article (PubMed ID: 19709362)
1. Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy.
D'Ambrosio R; Della Corte C; Colombo M
Int J Mol Sci; 2015 Aug; 16(8):19698-712. PubMed ID: 26295392
[TBL] [Abstract][Full Text] [Related]
2. Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.
Veldt BJ; Saracco G; Boyer N; Cammà C; Bellobuono A; Hopf U; Castillo I; Weiland O; Nevens F; Hansen BE; Schalm SW
Gut; 2004 Oct; 53(10):1504-8. PubMed ID: 15361504
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma.
Lu M; Li J; Rupp LB; Holmberg SD; Moorman AC; Spradling PR; Teshale EH; Zhou Y; Boscarino JA; Schmidt MA; Lamerato LE; Trinacty C; Trudeau S; Gordon SC;
J Viral Hepat; 2016 Sep; 23(9):718-29. PubMed ID: 27028626
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis C regiments containing with recombinant interferon in patients with sustained virological response predicts risk of hepatocellular carcinoma: A meta-analysis.
Li CF; Tsao SM; Liao HH; Chen SC; Lee YT
Medicine (Baltimore); 2020 Oct; 99(40):e22435. PubMed ID: 33019424
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves.
El Kassas M; Tawheed A; Eltabbakh M; Kaseb A
J Hepatocell Carcinoma; 2019; 6():183-191. PubMed ID: 31819865
[TBL] [Abstract][Full Text] [Related]
6. Elevated α-Fetoprotein in the Absence of Carcinoma Caused by Relapse of Hepatitis C Viral Infection after Liver Transplantation.
Kogiso T; Sagawa T; Kotera Y; Egawa H; Yamamoto M; Tokushige K
ACG Case Rep J; 2018; 5():e103. PubMed ID: 30643846
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Antiviral Therapy for Chronic Hepatitis C.
Tamori A; Enomoto M; Kawada N
Mediators Inflamm; 2016; 2016():6841628. PubMed ID: 27022210
[TBL] [Abstract][Full Text] [Related]
8. Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.
Nishikawa H; Osaki Y
Mediators Inflamm; 2015; 2015():872152. PubMed ID: 26494949
[TBL] [Abstract][Full Text] [Related]
9. Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits.
Smith-Palmer J; Cerri K; Valentine W
BMC Infect Dis; 2015 Jan; 15():19. PubMed ID: 25596623
[TBL] [Abstract][Full Text] [Related]
10. Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?
Gurusamy KS; Wilson E; Koretz RL; Allen VB; Davidson BR; Burroughs AK; Gluud C
PLoS One; 2013; 8(12):e83313. PubMed ID: 24349487
[TBL] [Abstract][Full Text] [Related]
11. Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study.
Nishiguchi S; Enomoto H; Aizawa N; Nishikawa H; Osaki Y; Tsuda Y; Higuchi K; Okazaki K; Seki T; Kim SR; Hongo Y; Jyomura H; Nishida N; Kudo M
J Gastroenterol; 2014 Mar; 49(3):492-501. PubMed ID: 23543311
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.
Selimovic D; El-Khattouti A; Ghozlan H; Haikel Y; Abdelkader O; Hassan M
World J Hepatol; 2012 Dec; 4(12):342-55. PubMed ID: 23355912
[TBL] [Abstract][Full Text] [Related]
13. The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients.
Nishikawa H; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Kita R; Kimura T; Osaki Y
BMC Res Notes; 2012 Mar; 5():135. PubMed ID: 22405406
[TBL] [Abstract][Full Text] [Related]
14. Effect of previous interferon treatment on outcome after curative treatment for hepatitis C virus-related hepatocellular carcinoma.
Miyatake H; Kobayashi Y; Iwasaki Y; Nakamura S; Ohnishi H; Kuwaki K; Toshimori J; Hagihara H; Nouso K; Yamamoto K
Dig Dis Sci; 2012 Apr; 57(4):1092-101. PubMed ID: 21989822
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1.
Datta S; Hazari S; Chandra PK; Samara M; Poat B; Gunduz F; Wimley WC; Hauser H; Koster M; Lamaze C; Balart LA; Garry RF; Dash S
Virol J; 2011 Jul; 8():351. PubMed ID: 21756311
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C-related cirrhosis with sustained prevention of hepatocellular carcinoma recurrence by long-term administration of super-low-dose peginterferon-alpha 2b.
Mamori S; Mamori H
Case Rep Gastroenterol; 2011 Jan; 5(1):56-62. PubMed ID: 21537363
[TBL] [Abstract][Full Text] [Related]
17. Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders.
Imai Y; Tamura S; Tanaka H; Hiramatsu N; Kiso S; Doi Y; Inada M; Nagase T; Kitada T; Imanaka K; Fukuda K; Takehara T; Kasahara A; Hayashi N
J Viral Hepat; 2010 Mar; 17(3):185-91. PubMed ID: 19709362
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398
[TBL] [Abstract][Full Text] [Related]
19. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
Kobayashi S; Takeda T; Enomoto M; Tamori A; Kawada N; Habu D; Sakaguchi H; Kuroda T; Kioka K; Kim SR; Kanno T; Ueda T; Hirano M; Fujimoto S; Jomura H; Nishiguchi S; Seki S
Liver Int; 2007 Mar; 27(2):186-91. PubMed ID: 17311612
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
